Home › NDC Lookup › RxCUI directory › RxCUI 2631093

Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT Injection [Altu... — RxCUI 2631093

RxNorm drug concept · Semantic branded drug
RxCUI 2631093 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2631093
Official nameAntihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT Injection [Altuviiio]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAltuviiio 1 UNT Injection
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)5,535 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Antihemophilic factor (recombinant), Fc-VWF-XTEN... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT Injection [Altuviiio] RxCUI 2631093

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein 2631084
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 2631083
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Altuviiio 2631089
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injection 2631087
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injection 2645501
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injectable Product 2631086
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injectable Product 2660182
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injection [Altuviiio] 2631092
    • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injection [Altuviiio] 2654369
    • Altuviiio Injectable Product 2631091
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT Injection SCD · 2631088
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT SCDC · 2631085
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injection SCDF · 2631087
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injection SCDFP · 2645501
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injectable Product SCDG · 2631086
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injectable Product SCDGP · 2660182

Brand-Name Concepts

  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl 1 UNT [Altuviiio] SBDC · 2631090
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein Injection [Altuviiio] SBDF · 2631092
  • Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Injection [Altuviiio] SBDFP · 2654369
  • Altuviiio Injectable Product SBDG · 2631091
  • Altuviiio BN · 2631089

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 2631093 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71104-0978-01 1 KIT in 1 KIT (71104-978-01) * 3 mL in 1 VIAL (71104-985-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
71104-0979-01 1 KIT in 1 KIT (71104-979-01) * 3 mL in 1 VIAL (71104-986-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
71104-0981-01 1 KIT in 1 KIT (71104-981-01) * 3 mL in 1 VIAL (71104-988-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
71104-0982-01 1 KIT in 1 KIT (71104-982-01) * 3 mL in 1 VIAL (71104-989-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
71104-0983-01 1 KIT in 1 KIT (71104-983-01) * 3 mL in 1 VIAL (71104-990-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
71104-0984-01 1 KIT in 1 KIT (71104-984-01) * 3 mL in 1 VIAL (71104-991-... ALTUVIIIO Bioverativ Therapeutics Inc. 2023-02-22
Observed labelers: Bioverativ Therapeutics Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7214 Altuviiio per factor viii iu 6 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.